Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses ...

On a morning in November 2023 Eamon Keenan, a psychiatrist who runs addiction services at Ireland’s state-funded health-care provider, received a worrying phone call. “People in homeless accommodation ...

Scientists at the University of Lausanne (UNIL) and University center Unisanté classified 35 commonly used drugs in Switzerland based on their impact on the aquatic biodiversity. Scientists at the ...

CHICAGO — A big breakthrough in cancer research and it’s all due to a tiny structure. The science was developed in Chicago. They took an old drug and made it better. The restructured drug appears to ...

Antibiotic resistance is one of the most urgent problems facing humanity, but it’s been decades since we last developed a new class of these drugs. That could all be about to change thanks to the ...

Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of the Atlantic. Nitazenes were first synthesized in the 1950s by CIBA ...

Sebastian Furness receives funding from the National Health and Medical Research Council and the Australian Research Council. Hundreds of thousands of people worldwide are taking drugs like Ozempic to ...